Anhui Nanwei Medical Products Co., Ltd. announced that it will receive CNY 75 million in an equity round of funding from returning investor Jiangsu Nanfang Medical Co., Ltd. (SHSE:603880) on February 25, 2021. The transaction has been approved by twentieth meeting of the third board of directors of the company and still needs to be submitted to the general meeting of shareholders for review. Post closing of the transaction, the registered capital of the company will increase from CNY 5 million to CNY 80 million and investor will retain 100% stake in the company. The company’s board of directors authorizes the company’s management to handle industrial and commercial approvals and other related matters.